> top > docs > PMC:7205724 > spans > 1428-1677 > annotations

PMC:7205724 / 1428-1677 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
51 82-85 Gene denotes IL6 Gene:3569
52 139-142 Gene denotes IL6 Gene:3569
60 15-23 Species denotes patients Tax:9606
61 120-128 Species denotes patients Tax:9606
62 183-192 Species denotes SARS-CoV2 Tax:2697049
64 39-50 Chemical denotes Tocilizumab MESH:C502936
76 29-37 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T5 65-73 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T6 193-197 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T17 29-37 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T18 183-187 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T19 244-248 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T5 52-53 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T6 193-197 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T3 193-197 http://purl.obolibrary.org/obo/CL_0000000 denotes cell

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T17 29-37 Species denotes COVID-19 NCBItxid:2697049
T18 183-192 Species denotes SARS-CoV2 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T19 39-150 Sentence denotes Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
60 15-23 Species denotes patients Tax:9606
76 29-37 Disease denotes COVID-19 MESH:C000657245
64 39-50 Chemical denotes Tocilizumab MESH:C502936
51 82-85 Gene denotes IL6 Gene:3569
61 120-128 Species denotes patients Tax:9606
52 139-142 Gene denotes IL6 Gene:3569
62 183-192 Species denotes SARS-CoV2 Tax:2697049

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T177 82-85 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T221 139-142 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T217 2-11 NN denotes prognosis
T218 12-14 IN denotes of
T219 15-23 NNS denotes patients
T220 24-28 IN denotes with
T221 29-37 NN denotes COVID-19
T222 39-50 NNP denotes Tocilizumab
T223 50-51 -COMMA- denotes ,
T224 52-53 DT denotes a
T225 54-64 JJ denotes monoclonal
T226 65-73 NN denotes antibody
T227 74-81 IN denotes against
T228 82-85 NN denotes IL6
T229 85-86 -COMMA- denotes ,
T230 87-92 MD denotes could
T231 93-99 VB denotes confer
T232 100-108 JJ denotes clinical
T233 109-116 NN denotes benefit
T234 117-119 IN denotes in
T235 120-128 NNS denotes patients
T236 129-133 IN denotes with
T237 134-138 JJ denotes high
T238 139-142 NN denotes IL6
T239 143-149 NNS denotes levels
T240 151-160 JJ denotes Essential
T241 161-169 NNS denotes elements
T242 170-174 IN denotes that
T243 175-182 NN denotes process
T244 183-192 NN denotes SARS-CoV2
T245 193-197 NN denotes cell
T246 198-203 NN denotes entry
T247 204-207 CC denotes and
T248 208-216 JJ denotes specific
T249 217-232 NNS denotes characteristics
T250 233-237 WDT denotes that
T251 238-243 VBP denotes allow
R209 T217 T218 arg1Of prognosis,of
R210 T219 T218 arg2Of patients,of
R211 T219 T220 arg1Of patients,with
R212 T221 T220 arg2Of COVID-19,with
R213 T222 T223 arg1Of Tocilizumab,","
R214 T226 T223 arg2Of antibody,","
R215 T226 T224 arg1Of antibody,a
R216 T226 T225 arg1Of antibody,monoclonal
R217 T226 T227 arg1Of antibody,against
R218 T228 T227 arg2Of IL6,against
R219 T231 T229 arg1Of confer,","
R220 T222 T230 arg1Of Tocilizumab,could
R221 T231 T230 arg2Of confer,could
R222 T222 T231 arg1Of Tocilizumab,confer
R223 T233 T231 arg2Of benefit,confer
R224 T233 T232 arg1Of benefit,clinical
R225 T231 T234 arg1Of confer,in
R226 T235 T234 arg2Of patients,in
R227 T235 T236 arg1Of patients,with
R228 T239 T236 arg2Of levels,with
R229 T239 T237 arg1Of levels,high
R230 T239 T238 arg1Of levels,IL6
R231 T241 T240 arg1Of elements,Essential
R232 T241 T242 arg1Of elements,that
R233 T247 T242 arg2Of and,that
R235 T246 T243 arg1Of entry,process
R236 T246 T244 arg1Of entry,SARS-CoV2
R237 T246 T245 arg1Of entry,cell
R238 T246 T247 arg1Of entry,and
R239 T249 T247 arg2Of characteristics,and
R240 T249 T248 arg1Of characteristics,specific
R241 T249 T250 arg1Of characteristics,that
R242 T249 T251 arg1Of characteristics,allow

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T5 65-73 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871
T6 193-197 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T17 29-37 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T18 183-192 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T19 39-150 Sentence denotes Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels.